Aptevo Therapeutics Inc.

APVO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Feb 10, 2022
8-K Feb 9, 2022 8-K
4 Feb 1, 2022
4 Feb 1, 2022
8-K Jan 21, 2022 APVO-2022-01-21 8K
4 Dec 7, 2021
4 Nov 26, 2021 FORM 4 SUBMISSION
SC 13D/A Nov 26, 2021 AMENDMENT NO. 5
8-K Nov 23, 2021 APVO-2021-11-23 8K
SC 13D/A Nov 22, 2021 AMENDMENT NO. 4
4 Nov 22, 2021 FORM 4 SUBMISSION
8-K Nov 12, 2021 8-K
10-Q Nov 12, 2021 10-Q
8-K Nov 5, 2021 8-K
8-K Aug 27, 2021 8-K
EFFECT Aug 19, 2021
CORRESP Aug 17, 2021
UPLOAD Aug 17, 2021
8-K Aug 17, 2021 8-K
S-3 Aug 12, 2021 S-3
8-K Aug 12, 2021 8-K
10-Q Aug 12, 2021 10-Q
8-K Jun 28, 2021 8-K
DEFA14A Jun 21, 2021 DEFA14A
SC 13D/A Jun 21, 2021 AMENDMENT NO. 3
← Newer Page 16 of 30 · 735 filings Older →